Hasan S T, Marshall C, Robson W A, Neal D E
Department of Urology, Freeman Hospital, Newcastle upon Tyne, UK.
Br J Urol. 1995 Nov;76(5):551-7. doi: 10.1111/j.1464-410x.1995.tb07777.x.
To study the long-term outcome of patients undergoing enterocystoplasty.
The study comprised 48 patients (17 men and 31 women; mean age 46 years) who underwent enterocystoplasty for idiopathic detrusor instability (DI, 35 patients) or neurogenic bladder dysfunction (13 patients). Symptoms were scored from 0 to 14 and the overall outcome and generic quality of life were assessed using a Visick grading system (groups A to E) and the Nottingham Health Profile (NHP). These assessments were carried out before, 3 months after operation and at the final follow-up (38 +/- 18 months, range 13-78). Urodynamic studies were performed before and after operation.
No patient died after operation and there was minimal early morbidity. Late complications (> 30 days) included incisional hernia (3), anastomotic perforation (1), calculus formation (1) and urethral stricture (1). Clean intermittent self-catheterization (CISC) was performed by 36 (75%) patients. Early symptomatic outcome was good in 40 (83%) patients, moderate in seven (15%) and unsatisfactory in one (2%) patient. The mean symptom scores before and 3 months after surgery were 10 (range 2-14) and 3 (range 2-14), respectively (P < 0.001). There was a significant increase in total bladder capacity (307 +/- 140 to 588 +/- 217 mL; P < 0.001) and bladder compliance (37 +/- 50 to 169 +/- 162 mL/cm H2O; P < 0.001). DI persisted in 15 (31%) patients. NHP scores revealed significant improvements in all domains. Final assessment showed a less satisfactory situation, with recurrent urinary tract infection (UTI) in 17 (37%) patients, a need for long-term antibiotic therapy in seven (15%) and a change in bowel habit in 15 (33%) (13 DI, two with neurogenic bladder dysfunction). CISC was performed by 39 (85%) patients. The long-term outcome was good or moderate in 12 patients (92%) with neurogenic bladder dysfunction and good or moderate in only 19 patients (58%) with DI.
Clam enterocystoplasty remains an effective management option in some patients with DI, but most patients with neurogenic bladder dysfunction do well. The procedure is, however, associated with long-term complications such as disturbance of bowel habit and recurrent UTIs, which impair the outcome in the long-term in patients with DI despite general improvements in irritative bladder symptoms.
研究接受肠膀胱扩大术患者的长期预后。
本研究纳入48例患者(17例男性和31例女性;平均年龄46岁),这些患者因特发性逼尿肌不稳定(DI,35例患者)或神经源性膀胱功能障碍(13例患者)接受了肠膀胱扩大术。症状评分从0至14分,使用Visick分级系统(A至E组)和诺丁汉健康量表(NHP)评估总体预后和一般生活质量。这些评估在术前、术后3个月及最终随访时(38±18个月,范围13 - 78个月)进行。术前和术后均进行了尿动力学研究。
术后无患者死亡,早期并发症极少。晚期并发症(>30天)包括切口疝(3例)、吻合口穿孔(1例)、结石形成(1例)和尿道狭窄(1例)。36例(75%)患者进行了清洁间歇性自家导尿(CISC)。40例(83%)患者早期症状改善良好,7例(15%)改善中等,1例(2%)患者不满意。术前和术后3个月的平均症状评分分别为10分(范围2 - 14分)和3分(范围2 - 14分)(P < 0.001)。膀胱总容量显著增加(307±140至588±217 mL;P < 0.001),膀胱顺应性也显著增加(37±50至169±162 mL/cm H₂O;P < 0.001)。15例(31%)患者DI持续存在。NHP评分显示所有领域均有显著改善。最终评估显示情况不太理想,17例(37%)患者反复发生尿路感染(UTI),7例(15%)患者需要长期抗生素治疗,15例(33%)患者排便习惯改变(13例DI患者,2例神经源性膀胱功能障碍患者)。39例(85%)患者进行了CISC。12例(92%)神经源性膀胱功能障碍患者的长期预后良好或中等,而DI患者中只有19例(58%)长期预后良好或中等。
对于一些DI患者,原位肠膀胱扩大术仍是一种有效的治疗选择,但大多数神经源性膀胱功能障碍患者预后良好。然而,该手术与长期并发症相关,如排便习惯改变和反复UTI,尽管膀胱刺激症状总体有所改善,但这些并发症会长期影响DI患者的预后。